System from Quest Diagnostics’ products business is first FDA-cleared Herpes Simplex Virus 1 and 2 test that uses genital swab or cerebrospinal fluid (CSF) specimen collection Quest Diagnostics (NYSE: ...
WOBURN, Mass. and OXFORD, England, July 8, 2022 /PRNewswire/ -- Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, today announced ...
Please provide your email address to receive an email when new articles are posted on . Despite a decline in herpes simplex virus type 2 infections over the course of decades, researchers calculated ...
To examine whether local immunization in the absence of secondary lymphoid organs (SLOs) could establish effective antiviral memory responses in the female genital tract, we examined immunity in the ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. WASHINGTON — The therapeutic vaccine candidate GEN-003 ...
Herpes simplex virus 2 (HSV-2) is a sexually transmitted infection that can cause painful, recurrent lesions in the genital skin and mucosa. HSV-2 initially infects genital epithelial cells before ...
Many viral infections, including HIV, are acquired at mucosal surfaces, necessitating the characterization of the immune environment at these barrier tissues. Unfortunately, clinical HIV research ...
Asymptomatic herpes simplex virus type 2 (HSV-2) infection is well described, but its natural history and relative transmissibility remain unclear. In this prospective study, researchers evaluated the ...
In a recent study published in the Advanced Science journal, researchers assessed the effectiveness of synthetic mucin gels in the inhibition of human immunodeficiency virus-1 (HIV-1) and herpes ...
Assembly Biosciences Inc. has selected development candidate ABI-5366 to progress to IND-enabling studies from its long-acting herpes simplex virus type 2 (HSV-2) helicase inhibitor program for ...
Serum YKL-40 levels in patients with cervical cancer are elevated compared to patients with cervical intraepithelial neoplasia and healthy controls No significant financial relationships to disclose.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results